Wikipedia:Articles for deletion/ImmunityBio


 * The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review).  No further edits should be made to this page.

The result was soft delete. Based on minimal participation, this uncontroversial nomination is treated as an expired PROD (a.k.a. "soft deletion"). Editors can request the article's undeletion. Star  Mississippi  02:25, 28 May 2022 (UTC)

ImmunityBio

 * – ( View AfD View log | edits since nomination)

Not a notable company as it is only known for potentially create the first COVID-19 vaccine. CactiStaccingCrane (talk) 02:15, 6 May 2022 (UTC)
 * Note: This discussion has been included in the deletion sorting lists for the following topics: Organizations, Companies,  and New York.  CAPTAIN RAJU (T) 02:24, 6 May 2022 (UTC)

Please add new comments below this notice. Thanks, Ks0stm  (T•C•G•E) 06:51, 13 May 2022 (UTC)
 * That's not true. According to Reuters "Its clinical pipeline consists of approximately 26 actively recruiting clinical trials of which 17 are in Phase II or III development, across 13 indications in liquid and solid tumors, including bladder, pancreatic, and lung cancers, and infectious diseases, including SARS-CoV-2 and human immunodeficiency virus (HIV)." The company is notable. Graham Beards (talk) 20:08, 6 May 2022 (UTC)
 * Any links to references? We need references that meet NCORP criteria for establishing notability in order to Keep this article.  HighKing++ 19:46, 25 May 2022 (UTC)
 *  Relisted to generate a more thorough discussion and clearer consensus.

Please add new comments below this notice. Thanks, Liz Read! Talk! 05:57, 20 May 2022 (UTC)
 * Delete Since this is a company the appropriate guidelines is WP:NCORP. I have to agree with the nom. We've some references that discusses the product (the vaccine and its technology or its "billionaire" owner) but the criteria dictates we require references that provide in-depth "Independent Content" about the *company*.  HighKing++ 16:06, 16 May 2022 (UTC)
 *  Relisted to generate a more thorough discussion and clearer consensus.


 * The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.